Cutting-Edge 3D Printing Technology for Drug Delivery and Tissue Engineering
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 62
Special Issue Editors
Interests: biomedical engineering; biomaterials; polimers; local delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: confocal microscopy; tissue engineering; bioresorbable materials; additive manufacture; molecular profiles by flow cytometry, biocompatibility, and cell differentiation
Special Issue Information
Dear Colleagues,
Three-dimensional printing and tissue engineering are revolutionizing biomedical applications, leveraging advanced techniques like additive manufacturing to create complex structures that mimic tissue morphology, induce remodeling and healing, and produce customized implants or organ models, thereby enhancing precision in medical treatments. This innovative approach uses bioresorbable materials, with or without bioactive molecules, to construct scaffolds that support cell growth. State-of-the-art imaging plays a crucial role in this field, providing high-resolution views of the three-dimensional scaffolds designed to optimize these engineered tissues. The integration of bioresorbable materials ensures that these constructs gradually degrade as natural tissue regenerates, reducing the need for additional surgeries.
Recent advancements in drug delivery systems have further expanded the potential of 3D printing technology. By developing sophisticated delivery systems, when 3D biomaterials are associated with specific molecules or cells, these agents can be directly controlled and be induced by a sustained release to the target site. This approach not only enhances the effectiveness of the treatment but also minimizes systemic side effects and improves patient compliance. The ability to precisely control the spatial and temporal distribution of therapeutic agents within the printed constructs is paving the way for more effective and personalized treatments. It holds significant promise for advancing regenerative medicine and personalized healthcare, offering new solutions for previously untreatable conditions and improving patient outcomes.
I kindly invite you to contribute your groundbreaking research to our upcoming Special Issue, showcasing how 3D printing technology is transforming drug delivery and tissue engineering. This Special Issue aims to highlight biomedical applications through the use of additive manufacturing, bioresorbable materials, and state-of-the-art imaging techniques. Three-dimensional biomaterials, featuring the delivery of bioactive molecules, are strongly desired. Your expertise and innovative work in creating complex structures that mimic tissue morphology, induce remodeling and healing, and produce customized implants or organ models are invaluable to advancing our collective understanding and application of these technologies. By sharing your research, you can help shape the future of regenerative medicine and personalized healthcare, offering new solutions for previously untreatable conditions and improving patient outcomes.
We eagerly anticipate your contributions to this Special Issue and look forward to showcasing the remarkable advancements in this dynamic field.
Prof. Dr. Eliana Aparecida de Rezende Duek
Prof. Dr. Moema Hausen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- additive manufacturing
- smart materials
- bioactive molecules
- drug delivery systems
- tissue engineering
- biomaterials for tissue healing
- 3D scaffolds
- cell therapy with biomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
